# Gut Microbiota and Dopamine: Producers, Consumers, Enzymatic Mechanisms, and In Vivo Insights

**Authors:** Giovanni Albani, Vasuki Ranjani Chellamuthu, Lea Morlacchi, Federica Zirone, Maryam Youssefi, Marica Giardini, Yin-Xia Chao, Eng-King Tan, Salvatore Albani

PMC · DOI: 10.3390/bioengineering13010055 · Bioengineering · 2025-12-31

## TL;DR

This paper explores how gut bacteria influence dopamine levels through specific enzymes, offering potential for new treatments in brain-related disorders.

## Contribution

The paper identifies bacterial enzymes and taxa involved in dopamine metabolism, suggesting new therapeutic strategies.

## Key findings

- Certain gut bacteria can produce dopamine via enzymes like TDC and AADC.
- Strain-specific microbial interactions may allow personalized treatments for dopamine-related disorders.
- New technologies like biosensors can help study microbial dopamine activity in vivo.

## Abstract

The human gut microbiota plays a key role in neurochemical communication, especially through the gut–brain axis. There is growing evidence that the gut microbiota influences dopamine metabolism through both production and consumption mechanisms. Two key bacterial enzymes are central to this process: tyrosine decarboxylase (TDC), which primarily catalyzes the decarboxylation of tyrosine to tyramine but can also act on L-DOPA to produce dopamine in certain bacterial strains, and aromatic L-amino acid decarboxylase (AADC), which can convert precursors such as L-DOPA, tryptophan, or 5-hydroxytryptophan into bioactive amines including dopamine, tryptamine, and serotonin. Identifying the bacterial families corresponding to TDC and AADC enzymes opens new avenues for clinical intervention, particularly in neuropsychiatric and neurodegenerative disorders, such as Parkinson’s disease. Moreover, elucidating strain-specific microbial contribution and host-microbe interactions may enable personalized therapeutic strategies, such as selective microbial enzyme inhibitors or tailored probiotics, to optimize dopamine metabolism. Emerging technologies, including biosensors and organ-on-chip platforms, offer new tools to monitor and manipulate microbial dopamine activity. This article explores the bacterial taxa capable of producing or consuming dopamine, focusing on the enzymatic mechanisms involved and the methodologies available for studying these processes in vivo.

## Linked entities

- **Proteins:** Tdc (transducin / WD-40 repeat protein, putative), DDC (dopa decarboxylase)
- **Chemicals:** tyrosine (PubChem CID 1153), tyramine (PubChem CID 5610), L-DOPA (PubChem CID 6047), dopamine (PubChem CID 681), tryptophan (PubChem CID 1148), 5-hydroxytryptophan (PubChem CID 144), tryptamine (PubChem CID 1150), serotonin (PubChem CID 5202)
- **Diseases:** Parkinson’s disease (MONDO:0005180)

## Full-text entities

- **Genes:** DDC (dopa decarboxylase) [NCBI Gene 1644] {aka AADC}
- **Diseases:** neuropsychiatric and neurodegenerative disorders (MESH:D019636), Parkinson's disease (MESH:D010300)
- **Chemicals:** tryptophan (MESH:D014364), tyramine (MESH:D014439), L-DOPA (MESH:D007980), Dopamine (MESH:D004298), tryptamine (MESH:C030820), tyrosine (MESH:D014443), amines (MESH:D000588), serotonin (MESH:D012701), 5-hydroxytryptophan (MESH:D006916)
- **Species:** Homo sapiens (human, species) [taxon 9606]

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12837447/full.md

## Figures

2 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12837447/full.md

## References

90 references — full list in the complete paper: https://tomesphere.com/paper/PMC12837447/full.md

---
Source: https://tomesphere.com/paper/PMC12837447